Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2013-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-013-2114-0PMID 23420438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

  2013cited by this paper
• Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification

  2011cited by this paper
• Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer

  2011cited by this paper
• The prognostic value of functional tumor volume and total lesion glycolysis in patients with colorectal cancer liver metastases undergoing 90Y selective internal radiation therapy plus chemotherapy

  2011cited by this paper
• Evaluation of 18F-FDG-PET for Early Detection of Suboptimal Response of Rectal Cancer to Preoperative Chemoradiotherapy: A Prospective Analysis

  2011cited by this paper
• Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer.

  2011cited by this paper
• Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome

  2011cited by this paper
• Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification

  2010cited by this paper
• Early 18F‐2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography may identify a subset of patients with estrogen receptor‐positive breast cancer who will not respond optimally to preoperative chemotherapy

  2010cited by this paper
• Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications

  2010cited by this paper
• Treatment for Patients with Rectal Cancer and a Clinical Complete Response to Neoadjuvant Therapy: A Decision Analysis

  2009cited by this paper
• Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

  2009cited by this paper
• Non‐operative management of rectal cancer after neoadjuvant chemoradiation

  2009cited by this paper
• A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic stem cell transplantation.

  2008cited by this paper
• The “y” symbol: An important classification tool for neoadjuvant cancer treatment

  2006cited by this paper
• How Accurate is Magnetic Resonance Imaging in Restaging Rectal Cancer in Patients Receiving Preoperative Combined Chemoradiotherapy?

  2005cited by this paper
• Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.

  2005cited by this paper
• Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?

  2005cited by this paper
• Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit?

  2004cited by this paper
• Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology

  2004cited by this paper
• Preoperative versus postoperative chemoradiotherapy for rectal cancer.

  2004cited by this paper
• Complete Pathologic Response Following Preoperative Chemoradiation Therapy for Middle to Lower Rectal Cancer Is Not a Prognostic Factor for a Better Outcome

  2004cited by this paper
• 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.

  2004cited by this paper
• Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.

  2003cited by this paper
• AJCC Cancer Staging Manual. 6th ed

  2002cited by this paper
• Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

  2001cited by this paper
• Use of PET to monitor the response of lung cancer to radiation treatment

  2000cited by this paper
• Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer

  1999cited by this paper
• Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

  1999cited by this paper

• Early prediction of histopathological response of locally advanced rectal cancer after 1 week of preoperative radiochemotherapy using 18FDG PET-CT imaging: a prospective clinical validation study

  2025cites this paper
• Predicción de la respuesta completa a la quimiorradioterapia neoadyuvante en el cáncer de recto localmente avanzado: papel de los parámetros volumétricos basales de la PET/TC con [18F]FDG y los marcadores inflamatorios

  2025cites this paper
• Predicting Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: The Role of Baseline Volumetric 18F-FDG PET/CT Parameters and Inflammatory Markers.

  2025cites this paper
• The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy

  2025cites this paper
• Clinical utility and future directions of FDG-PET in rectal cancer management

  2025cites this paper
• Imaging glucose metabolism to reveal tumor progression

  2023cites this paper
• Heterogeneidad del tumor primario en la18F-FDG PET/TC pretratamiento para predecir el pronóstico en pacientes con cáncer de recto sometidos a cirugía tras terapia neoadyuvante

  2023cites this paper
• Primary tumor heterogeneity on pretreatment 18F-FDG PET/CT to predict outcome in patients with rectal cancer who underwent surgery after neoadjuvant therapy.

  2023cites this paper
• Evaluación de la supervivencia de los pacientes con cáncer de recto metastásico mediante parámetros radiómicos y volumétricos de la PET/TC con [18F]FDG de estadificación

  2022cites this paper
• Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative 18F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease

  2022cites this paper
• Prediction value of 18F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer

  2022cites this paper
• Evaluation of survival of the patients with metastatic rectal cancer by staging 18F-FDG PET/CT radiomic and volumetric parameters.

  2022cites this paper
• 18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer

  2022cites this paper
• The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

  2021cites this paper
• Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery

  2021cites this paper
• Role of Imaging in Colorectal Cancers

  2020cites this paper
• Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer

  2020cites this paper
• Predicting pathological response to chemoradiotherapy for rectal cancer: a systematic review

  2020cites this paper
• Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer

  2019cites this paper
• Individualized threshold for tumor segmentation in 18F-FDG PET/CT imaging: The key for response evaluation of neoadjuvant chemoradiation therapy in patients with rectal cancer?

  2018cites this paper
• Value of FDG–PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer

  2018cites this paper
• FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer

  2017cites this paper
• Role of PET/CT in Radiotherapy Treatment Planning

  2017cites this paper
• Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

  2016cites this paper
• Outcomes of Preoperative Chemoradiotherapy and Combined Chemotherapy with Radiotherapy Without Surgery for Locally Advanced Rectal Cancer.

  2016cites this paper
• Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer

  2016cites this paper
• (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.

  2016cites this paper
• Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study

  2016cites this paper
• 18 F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status

  2016cites this paper
• Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

  2015cites this paper
• Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review

  2015cites this paper
• Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response

  2015cites this paper
• Comparison of 18F-FDG PET/CT methods of analysis for predicting response to neoadjuvant chemoradiation therapy in patients with locally advanced low rectal cancer

  2015cites this paper
• Volumetric Parameters Changes of Sequential 18F-FDG PET/CT for Early Prediction of Recurrence and Death in Patients With Locally Advanced Rectal Cancer Treated With Preoperative Chemoradiotherapy

  2015cites this paper
• Systematic Review of FDG-PET Prediction of Complete Pathological Response and Survival in Rectal Cancer

  2014cites this paper
• The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.

  2014cites this paper
• MRI and FDG-PET for Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer

  2014cites this paper
• Systematic Review of FDG-PET Prediction of Complete Pathological Response and Survival in Rectal Cancer

  2014influential citation
• Locally advanced rectal cancer: new findings in anticancer therapy

  2013cites this paper
• Quantitative PET factors predictive of the response to therapy in solid tumors: which is the best?

  2013cites this paper